Key points
-
Vascular tumors are distinct from vascular malformations and should be appropriately classified according to the classification of the International Society for the Study of Vascular Anomalies (ISSVA); misdiagnosis and inappropriate nomenclature is frequent.
-
Infantile hemangiomas are the most frequent vascular tumors in children and most frequently do not require treatment.
-
Locally aggressive as well as borderline tumors can present with typical imaging appearance depending on their degree of vascularity. Complications of benign vascular tumors include ulceration and bleeding which require immediate therapy, consisting of medical, surgical, and interventional radiology approaches.
-
Minimally invasive image-guided treatment strategies can be used for palliation and to manage complications.
Introduction
Classification of vascular tumors
Benign vascular tumors | |
Infantile hemangioma | |
Congenital hemangioma | |
• Rapidly involuting (RICH)a | |
• Non-involuting (NICH) | |
• Partially involuting (PICH) | |
Tufted angiomaa | |
Spindle-cell hemangioma | |
Epitheloid hemangioma | |
Pyogenic granuloma | |
Others | |
Locally aggressive or borderline vascular tumors | |
Kaposiform hemangioendotheliomaa | |
Retiform hemangioendothelioma | |
Papillary intralymphatic angioendothelioma (PILA), Dabska tumor | |
Composite hemangioendothelioma | |
Pseudomyogenic hemangioendothelioma | |
Polymorpous hemangioendothelioma | |
Hemangioendothelioma not otherwise specified | |
Kaposi sarcoma | |
Others | |
Malignant vascular tumors | |
Angiosarcoma | |
Epitheloid hemangioendothelioma | |
Others |
Diagnostic imaging workup
Entity | Pathology | Clinical presentation | Imaging |
---|---|---|---|
Infantile hemangioma | GLUT-1 positive | Solid vascularized mass, cutaneous lesions present frequently as raspberry-like patches at any part of the body, lesion typically do not appear before 2 weeks of age | Rarely required, if required US most frequently sufficient |
Congenital hemangioma | GLUT-1 negative | Similar appearance compared to infantile hemangioma, present at birth | Rarely required, if required US most frequently sufficient |
Pyogenic granuloma | GLUT-1 negative | Small (≤ 1 cm), sessile or pedunculated red papule or nodule | Not required |
TA/kaposiform hemangioendothelioma | Positive for PROX-1, Podoplanin/D2–40, LYVE-1, CD31, and CD34 but GLUT-1 negative | Expanding ecchymotic firm mass with purpura and accompanying lymphedema | MRI including MR angiography recommended |
PILA/Dapska tumor | Peri- and intravascular lymphocytic infiltrates are common, endothelials cells frequently positive for CD31, CD34, ‘D2–40 and VEGFR-3 | Red infiltrating singular plaque, affecting cutis and subcutis | Not required |
Kaposi sarcoma | Immunoreactivity for LANA-1, an HHV-8 viral antigen is pathognomonic | Sharply demarcated patch or later plaque-like infiltrates of skin and subcutaneous tissue (cutaneous manifestations) | Imaging rarely required for cutaneous manifestation, recommended for visceral manifestations |
Epitheloid hemangioendothelioma | Positive for CD31 and factor VIII, variably for CD34, epitheloid endothelial cells within a hyalinized or myxoid stroma | Red-brownish plaque or nodule (cutaneous lesions) | MRI including MR angiography recommended, CT imaging for stating purpose |
Angiosarcoma | Positive for CD31 and CD34, and also for factor VIII, necrosis and hemorrhage common, angiosarcomas can be GLUT-1 positive | Diffuse infiltrating mass, clinical findings rarely specific | MRI including MR angiography recommended, CT imaging for stating purpose, PET imaging may be helpful in dedicated cases |
Vascular tumors | ||||
---|---|---|---|---|
Hemangioma (infantile/congenital) | Tufted angioma/kaposiform hemangioendothelioma | Epitheloid hemangioendothelioma | Angiosarcoma | |
MRI morphology | Solid, frequently homogeneous well-defined mass | Diffuse infiltrating mass permeating all soft tissue structures | Solid mass with ill-defined margins | Diffuse inhomogeneous mass, infiltrating all tissue types |
MRI signal | ||||
T1 pre-contrast | Isointense to muscle | Isointense to muscle | Isointense to muscle | Isointense to muscle |
T2 (to be performed with fat saturation) | Hyperintense to muscle | Hyperintense to muscle, septal architecture perpendicular to the skin, often with edema | Moderate hyperintense to muscle | Hyperintense to muscle |
Fat-saturated T1 post-contrast | Hyperintense to muscle and flow-voids | Hyperintense to muscle, septal enhancement | Moderate hyperintense to muscle | Hyperintense to muscle (central necrosis frequent) |
MRI flow-characteristics | ||||
MR-angiography | Fast-flow, tumor blush | Fast flow, tumor blush | Slow flow | Slow-flow |
Imaging differential diagnosis | Venous (in case of slow flow hemangioma) or arteriovenous malformation (in case of fast-flow), KHE, macular stains/capillary malformation, soft tissue sarcoma | Hemangioma, soft tissue sarcoma, extraosseus Ewing sarcoma, kaposiform lymphangiomatosis | Hemangioma (such as epitheloid hemangioma), HCC (in case of liver manifestation), lymphoma (in case of lymphatic manifestation), sarcoma | Can mimic any malignant highly vascularized tumor (breast, soft tissue, bone, visceral, head, and neck), intravascular angiosarcoma can resemble thrombosis or atheroma |
Sequence | Alternative |
---|---|
T1 SE | |
STIR/TIRM (recommended in at least two planes) | T2 Dixon, PD with fat-saturation (in case of small field of view/region of interest) |
Dynamic MR angiography (especially in case of suspected fast-flow) | |
T1 with fat-saturation after gadolinium administration (recommended in two planes) | T1 Dixon after gadolinium administration |